| Q36726900 | A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice |
| Q51901247 | CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. |
| Q36953224 | Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm |
| Q35237163 | Epigenetic approaches to psychiatric disorders |
| Q39974513 | Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site. |
| Q37104140 | GABA(A) receptors in normal development and seizures: friends or foes? |
| Q36713347 | Molecular genetics of bipolar disorder and depression. |
| Q33912426 | Mutations affecting GABAergic signaling in seizures and epilepsy |
| Q53520313 | No association of trace amine receptor genes with bipolar disorder. |
| Q36947233 | PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis |
| Q33389202 | Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission |
| Q26864902 | Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts |
| Q37724316 | Proteome dynamics during postnatal mouse corpus callosum development |
| Q30487718 | Sexually dimorphic expression of KCC2 and GABA function |
| Q22251105 | The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions |